Evidence map›Paper›PMID 31570354›Full record

ArticleBMJ case reports2019

Mike Wang, Nour Kibbi, Nan Ring, Alexa Siddon, Francine Foss, Mariam Totonchy

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mike WangDermatology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0001-6487-5912
Nour KibbiDermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Nan RingDermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Alexa SiddonLaboratory Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Francine FossDermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Mariam TotonchyDermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with AIDS have increased risk of developing lymphomas, such as anaplastic large cell lymphoma (ALCL), which generally carry a poor prognosis. The

Indexed as

Anaplastic Lymphoma KinaseAntineoplastic Agents, ImmunologicalBrentuximab VedotinDual-Specificity PhosphatasesGene RearrangementHumansLymphoma, AIDS-RelatedLymphoma, Large-Cell, AnaplasticMaleMiddle AgedMitogen-Activated Protein Kinase PhosphatasesSkin NeoplasmsTreatment OutcomeAnaplastic Lymphoma KinaseAntineoplastic Agents, ImmunologicalBrentuximab VedotinDual-Specificity PhosphatasesDUSP22 protein, humanMitogen-Activated Protein Kinase Phosphatasescancer interventiondermatologygeneticshaematology (incl blood transfusion)HIV/aids

Identifiers

PMID31570354
PMCPMC6768350
OpenAlexW2978211737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.